-
Mashup Score: 3
It will be ironic if fear of blood clots keeps people from getting coronavirus vaccines. Covid-19 itself causes blood clots — lots of them.
Source: CNNCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Doctors say fears of blood clots from J&J's shot are overdone and could delay the push to end the pandemic - 3 year(s) ago
Data suggests J&J’s and AstraZeneca’s COVID shots could carry a very rare risk of serious blood-clot problems.
Source: Business InsiderCategories: Hem/Oncs, Latest HeadlinesTweet-
Fears of blood clots with JnJ and AZ vaccines much overblown: https://t.co/smuWW6qtrw #WTD #isth #Canvector #Cardiotwitter @EuropeanTHA @NATFthrombosis #RPTH #thrombosisUK #ZuckerSOM @PERTConsortium
-
-
Mashup Score: 5Op-Ed: J&J Vax Pause Is Actually Good for COVID Long Game - 3 year(s) ago
May boost vaccine hesitancy right now, but the gain in public trust is more important
Source: www.medpagetoday.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Too much hysteria, too little understanding."Chances" of blood clot with JnJ/AZ vaccines 1 in a million, chances of blood clot risk when in-hospital with COVID 1 in 20 to 1 in 5: https://t.co/8UK56NknK2 #isth #WTD #Cardiotwitter #EuropeanTHA #thrombosisUK @NATFthrombosis #RPTH
-
-
Mashup Score: 3Post-Discharge Thromboembolic Outcomes and Mortality of Hospitalized COVID-19 Patients: The CORE-19 Registry - PubMed - 3 year(s) ago
Thromboembolic events including venous thromboembolism (VTE), arterial thromboembolism (ATE), and mortality from sub-clinical thrombotic events occur frequently in COVID-19 inpatients. Whether the risk extends post-discharge has been controversial. Our prospective registry included consecutive COVID …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
Large Registry: High Rate of Post-Discharge Thrombosis and Mortality in COVID-19 Pts and ~50% Risk Reduction with Post-Discharge Anticoagulants https://t.co/8zgbIVMzsV #WTD #isth #ZuckerSOM #Canvector #Cardiotwitter @EuropeanTHA @NATFthrombosis @AnticoagForum #RPTH #thrombosisUK
-
-
Mashup Score: 0Effect of Intermediate- vs Standard-Dose Anticoagulation on Outcomes of Patients With COVID-19 - 3 year(s) ago
This randomized trial compares the effect of intermediate-dose vs standard prophylactic enoxaparin on a composite outcome of acute venous thromboembolism (VTE), arterial thrombosis, need for extracorporeal membrane oxygenation (ECMO), and all-cause mortality within 30 days among patients with…
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
First published randomized trial: escalated dose LMWH without benefit in ICU COVID-19 patients: https://t.co/bDkOvOjPCN #WTDay21 #isth #ZuckerSOM #Canvector #Cardiotwitter @NATFthrombosis @EuropeanTHA #PERT #thrombosis #RPTH
-
-
Mashup Score: 1Hemostasis Science Weeks - 3 year(s) ago
Connecting experts around the world and across healthcare specialties
Source: www.siemens-healthineers.comCategories: Hem/Oncs, Latest HeadlinesTweet-
I'm excited to present at the Hemostasis Science Weeks. Join me and my fellow experts LIVE! You can register here: https://t.co/bsMxQJBiU2 #WTDay #ISTH #ZuckerSOM #Canvector #Cardiotwitter #EuropeanTHA #thrombosis @NATFthrombosis #PERT #ThrombosisUK #RPTH https://t.co/l2yyuEBRw7
-
You are more likely to be struck by lightning than get vaccine-induced thrombosis: https://t.co/JdDuHVNOSG @isth @NATFthrombosis @ThrombosisCan @canvector @PERTConsortium @ThrombosisUK #RPTH #CardioTwitter #WTD #ZuckerSOM #thrombosis @AnticoagForum